Cancer News and Research

Latest Cancer News and Research

SEGT helpful for breast cancer patients with affective disorders

A pilot investigation performed by a group of Italian investigators and published in the current issue of Psychotherapy and Psychosomatics indicates that supportive-expressive group therapy is helpful in patients with breast cancer.

16 Feb 2010

Meda publishes 2009 year-end report

“The Meda Group expects to achieve sales of about SEK 13,000 million and an EBITDA of about SEK 4,200 million for full-year 2009.”

16 Feb 2010

Overall benefits of HPV vaccination or frequent screening are low for women over 41

The overall potential benefits of human papillomavirus (HPV) vaccinations or frequent HPV screenings for women over the age of 41 are low, concludes a new study published online February 15 in the Journal of the National Cancer Institute. The study found that the rate of new infections preventable by vaccination declines with age. Furthermore, new infections among women at any age typically do not progress to cervical intraepithelial neoplasia grade 2 (CIN 2) or CIN 3, the precursors for cervical cancer.

16 Feb 2010

Accuray: Mount Vernon Cancer Centre acquires CyberKnife Robotic Radiosurgery System

Accuray Incorporated, a global leader in the field of radiosurgery, announced today that Mount Vernon Cancer Centre in the United Kingdom has become the first National Health Service hospital to acquire a CyberKnife® Robotic Radiosurgery System.

16 Feb 2010

AstraZeneca, Rigel Pharmaceuticals announce exclusive worldwide license agreement for R788

AstraZeneca and Rigel Pharmaceuticals today announced an exclusive worldwide license agreement for the global development and commercialization of fostamatinib disodium (R788), Rigel's late-stage investigational product for rheumatoid arthritis (RA) and additional indications.

16 Feb 2010

Three Dutch life-science sectors announce joint investment to research on personalized medicine

The Netherlands' three Top Institutes for life-science research (the BioMedical Materials program, the Center for Translational Molecular Medicine and Top Institute Pharma) today announced a joint investment of MEUR 28 on innovative research targeted at bringing personalized medicine closer to reality.

16 Feb 2010

Use of non-steroidal anti-inflammatory drugs not associated with risk of squamous cell skin cancer

Contrary to previous hypotheses, the use of non-steroidal anti-inflammatory drugs does not appear associated with risk of squamous cell skin cancer, according to a report posted online today that will appear in the April print issue of Archives of Dermatology, one of the JAMA/Archives journals.

16 Feb 2010

Clive Svendsen to receive American Academy of Neurology Sheila Essey Award for his research on ALS

Clive Svendsen, Ph.D., director of the Cedars-Sinai Regenerative Medicine Institute, is receiving the American Academy of Neurology Sheila Essey Award for his research on ALS (amyothrophic lateral sclerosis).

16 Feb 2010

Minority patients more likely to have surgeries at centres handling low numbers of similar procedures

Minority patients in New York City appear less likely than white patients to have surgeries performed by surgeons or at facilities that have handled large numbers of similar procedures in the past, according to a report in the February issue of Archives of Surgery, one of the JAMA/Archives journals.

16 Feb 2010

Over 96% of SIDS cases due to known risk factors

Sudden Infant Death Syndrome (SIDS) continues to be the third leading cause of infant death, according to the Centers for Disease Control (CDC), despite a decline in SIDS that is associated with a rise in safe-sleep practices for newborns and infants. A new study by Barbara M. Ostfeld, PhD and Thomas Hegyi, MD, professors in the Department of Pediatrics at UMDNJ-Robert Wood Johnson Medical School, has identified that more than 96 percent of infants who died of SIDS were exposed to known risk factors, among them sleeping on their side or stomach, or exposure to tobacco smoke, and that 78 percent of SIDS cases contained multiple risk factors.

16 Feb 2010

US Oncology honored as inaugural inductee to Texas Governor's Business Hall of Fame

US Oncology, Inc., the nation's premier oncology services company supporting the nation's largest network including more than 1,300 oncologists and more than 10,000 clinicians and cancer experts to advance cancer care in America, was honored on Feb. 6, by Texas Governor Rick Perry at the Texas vs. the Nation All-Star Football Challenge in El Paso, Texas. US Oncology was honored as an inaugural inductee to the Governor's Business Hall of Fame along with Baker Hughes, Bell Helicopter, and Texas Instruments.

16 Feb 2010

CNRS-Institut researchers identify 'virulence factor' that inhibits host immune response

Oncogenic retroviruses are a particular family of viruses that can cause some types of cancer. Thierry Heidmann and his colleagues in the CNRS-Institut Gustave Roussy-Université Paris Sud 11 "Rétrovirus endogènes et éléments rétroïdes des eucaryotes supérieurs" Laboratory have studied these viruses. They have identified a "virulence factor" that inhibits the host immune response and allows the virus to spread throughout the body.

16 Feb 2010

NorTech announces winners of annual Innovation Awards program

NorTech, in partnership with Crain's Cleveland Business, is pleased to announce the winners of its annual Innovation Awards program which honors the achievements of Northeast Ohio's most innovative organizations and leaders.

16 Feb 2010

Children's Hospital of Philadelphia awarded two grants to research into cellular therapies for blood disorders

The new decade may herald an era of cell therapy -- treating human diseases by delivering highly specific beneficial cells. In the wake of an NIH decision late last year permitting federally funded researchers to use new lines of human embryonic stem cells, the door has opened more widely to stem cell research.

16 Feb 2010

Public health researchers at UNC to lead multi-state initiative to prevent cervical cancer

Asserting that no one should die from cervical cancer, public health researchers at the University of North Carolina at Chapel Hill are leading a multi-state initiative to prevent - or even eradicate - the disease.

16 Feb 2010

Annual Income Tax Check-Off for Breast and Cervical Research campaign launched

The Pennsylvania Breast Cancer Coalition has launched its annual Income Tax Check-Off for Breast and Cervical Research campaign to fund PA researchers. By simply checking YES on line 35 of the PA 40 tax form, any taxpayer can donate all or part of their state income tax refund to breast and cervical cancer research.

16 Feb 2010

Researchers identify potential therapeutic targets for treatment of neuroblastoma

A team of researchers, led by Patrick Mehlen, at Universit- de Lyon, France, has identified the protein NT-3 and the cell-surface molecule to which it binds (TrkC) as potential therapeutic targets for the treatment of neuroblastoma - the most frequent solid tumor in young children- by studying human neuroblastoma cells in vitro and after xenotransplantation into mice and chicks.

15 Feb 2010

ERYtech Pharma announces collaborative research agreement with M. D. Anderson Cancer Center

ERYtech Pharma, a specialty pharma company located in France and in USA (Philadelphia), is pleased to announce a collaborative research agreement in the field of personalized medicine focusing on ERYtech’s flagship product, GRASPA®, which consists of red blood cell-encapsulated L-asparaginase (L-ASP).

15 Feb 2010

LCA announces new internet link with renowned lung cancer research center in Zhuhai, China

Lung Cancer Alliance (LCA) announced today a new internet link with a renown lung cancer research center at the 5th Affiliated Hospital of Sun Yat-Sen University, in Zhuhai, China.

15 Feb 2010

New conference to discuss issues surrounding breast cancer to take place at UWE

An opportunity to join a forum to discuss issues surrounding breast cancer is taking place at the University of the West of England on Saturday 3 July 2010.

15 Feb 2010

Cancer News and Research

Latest Cancer News and Research

SEGT helpful for breast cancer patients with affective disorders

Meda publishes 2009 year-end report

Overall benefits of HPV vaccination or frequent screening are low for women over 41

Accuray: Mount Vernon Cancer Centre acquires CyberKnife Robotic Radiosurgery System

AstraZeneca, Rigel Pharmaceuticals announce exclusive worldwide license agreement for R788

Three Dutch life-science sectors announce joint investment to research on personalized medicine

Use of non-steroidal anti-inflammatory drugs not associated with risk of squamous cell skin cancer

Clive Svendsen to receive American Academy of Neurology Sheila Essey Award for his research on ALS

Minority patients more likely to have surgeries at centres handling low numbers of similar procedures

Over 96% of SIDS cases due to known risk factors

US Oncology honored as inaugural inductee to Texas Governor's Business Hall of Fame

CNRS-Institut researchers identify 'virulence factor' that inhibits host immune response

NorTech announces winners of annual Innovation Awards program

Children's Hospital of Philadelphia awarded two grants to research into cellular therapies for blood disorders

Public health researchers at UNC to lead multi-state initiative to prevent cervical cancer

Annual Income Tax Check-Off for Breast and Cervical Research campaign launched

Researchers identify potential therapeutic targets for treatment of neuroblastoma

ERYtech Pharma announces collaborative research agreement with M. D. Anderson Cancer Center

LCA announces new internet link with renowned lung cancer research center in Zhuhai, China

New conference to discuss issues surrounding breast cancer to take place at UWE

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in